GT-EPIC Trademark

Trademark Overview


On Monday, July 22, 2019, a trademark application was filed for GT-EPIC with the United States Patent and Trademark Office. The USPTO has given the GT-EPIC trademark a serial number of 88527127. The federal status of this trademark filing is REGISTERED as of Tuesday, August 11, 2020. This trademark is owned by Geneos Therapeutics, Inc.. The GT-EPIC trademark is filed in the Pharmaceutical Products category with the following description:

Therapeutic pharmaceuticals for the personalized treatment of cancer and oncological conditions; pharmaceuticals, namely, immunotherapies for the personalized treatment of cancer and oncological conditions; immunotherapy products, namely, pharmaceutical products for the personalized treatment of cancer and oncological conditions
gt-epic

General Information


Serial Number88527127
Word MarkGT-EPIC
Filing DateMonday, July 22, 2019
Status700 - REGISTERED
Status DateTuesday, August 11, 2020
Registration Number6126051
Registration DateTuesday, August 11, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 19, 2019

Trademark Statements


Goods and ServicesTherapeutic pharmaceuticals for the personalized treatment of cancer and oncological conditions; pharmaceuticals, namely, immunotherapies for the personalized treatment of cancer and oncological conditions; immunotherapy products, namely, pharmaceutical products for the personalized treatment of cancer and oncological conditions
Pseudo MarkGENEOS THERAPEUTICS-EPIC

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 30, 2019
Primary Code005
First Use Anywhere DateWednesday, May 20, 2020
First Use In Commerce DateWednesday, May 20, 2020

Trademark Owner History


Party NameGeneos Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPlymouth Meeting, PA 19462

Party NameGeneos Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPlymouth Meeting, PA 19462

Party NameGeneos Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPlymouth Meeting, PA 19462

Trademark Events


Event DateEvent Description
Wednesday, January 3, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, January 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 11, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, July 8, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 7, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, June 25, 2020STATEMENT OF USE PROCESSING COMPLETE
Friday, June 5, 2020USE AMENDMENT FILED
Thursday, June 25, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 5, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, January 14, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 19, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 19, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 30, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 16, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 10, 2019ASSIGNED TO EXAMINER
Tuesday, July 30, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 25, 2019NEW APPLICATION ENTERED